BlueCrest Capital Management’s SOC Telemed, Inc. Class A Common Stock TLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-250,000
Closed -$1.96M 705
2020
Q4
$1.96M Sell
250,000
-600,000
-71% -$5.3M 0.04% 258
2020
Q3
$8.63M Buy
850,000
+750,000
+750% +$7.74M 0.32% 87
2020
Q2
$1M Buy
+100,000
New +$989K 0.05% 163

Other funds holding TLMD

BlueCrest Capital Management's TLMD Position: Q1 2021 in Review

BlueCrest Capital Management sold out of SOC Telemed, Inc. Class A Common Stock (TLMD) in Q1 2021, closing a stake of 250,000 shares — an estimated $1.96M sold.

BlueCrest Capital Management first reported a position in TLMD in Q2 2020 and held it in 3 quarters. The position peaked at $8.63M in Q3 2020. 64 funds tracked by Wall St. Rank hold TLMD as of Q1 2021.

  • BlueCrest Capital Management reported no remaining SOC Telemed, Inc. Class A Common Stock position as of Q1 2021 after selling out during the quarter.
  • BlueCrest Capital Management sold 250,000 SOC Telemed, Inc. Class A Common Stock shares in Q1 2021, an estimated $1.96M.
  • BlueCrest Capital Management first reported a position in SOC Telemed, Inc. Class A Common Stock in Q2 2020 and held it in 3 quarters.
  • BlueCrest Capital Management's SOC Telemed, Inc. Class A Common Stock position peaked at $8.63M in Q3 2020.
  • 64 funds tracked by Wall St. Rank held SOC Telemed, Inc. Class A Common Stock as of Q1 2021.

Based on BlueCrest Capital Management's 13F filing for Q1 2021, filed 17 May 2021.